AMPLICHIP CYP450 TEST 04381866190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05 report with the FDA on 2011-11-03 for AMPLICHIP CYP450 TEST 04381866190 manufactured by Roche Molecular Systems.

Event Text Entries

[2292820] A customer site in (b)(6) filed a complaint alleging discrepant results were obtained when using the amplichip cyp450 test. The sample was originally tested on (b)(6) 2009 and generated a result of *5*5 (poor metabolizer) for 2d6. In (b)(6) 2011, a breath test was done for this patient and these results did not fit with results of poor metabolizer. On (b)(6) 2011, two retests were done. The first was done with an eluate of the 2009 sample. The second retest was done with a new sample collection. The result was *1*1 (extensive metabolizer). It is not known at this time if that result is from the first or second retest. No patient treatment information is available.
Patient Sequence No: 1, Text Type: D, B5


[9383203] No conclusion can be drawn at this time as the investigation into this issue is ongoing. Conclusion from the investigation will be submitted through a follow-up report. Amplichip cyp450 us-ivd, product number 04591402190. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[9575848] Date of follow-up information was received. Follow up report 1. Device evaluated by manufacturer yes. No product or batch non-conformance was identified. The patient samples were not requested back as they were stored for approximately 2 years, which is not supported by the amplichip package insert sample storage claims. Furthermore, a new collection of the patient samples involved could not be obtained. Upon investigation there was no trend found in the field. Qc release data for n12926 was reviewed and the issue of discrepant results has not been observed. There have not been any manufacturing non-conformance reports for batch n12926. There are a few factors that can lead to the customer's observations, including but not limited to dna degradation, sample contamination or sample mix-up. As the samples were stored significantly beyond the storage claims, it cannot be reliable. . (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2011-00096
MDR Report Key2321329
Report Source01,05
Date Received2011-11-03
Date of Report2011-10-05
Date of Event2011-08-20
Date Mfgr Received2011-12-13
Device Manufacturer Date2010-02-19
Date Added to Maude2012-07-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationMEDICAL TECHNOLOGIST
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202S
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameAMPLICHIP CYP450 TEST
Generic NameDRUG METABOLIZING ENZYME GENOTYPING SYSTEMS
Product CodeNTI
Date Received2011-11-03
Catalog Number04381866190
Lot NumberN12926
Device Expiration Date2011-09-01
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HW 202S BRANCHBURG NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2011-11-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.